Lactic Acid Bacteria & Probiotics: Ingredient Traceability and Supply Chain Transparency

Abstract

The global supply chain for lactic acid bacteria (LAB) and probiotic ingredients spans multiple continents and involves numerous stages, including strain cultivation, fermentation production, freeze-drying processing, and excipient blending. Demands for ingredient traceability within Japan's health food market have risen year by year, with regulatory authorities, third-party certification bodies, and consumers alike placing increasing emphasis on core questions such as where ingredients come from, how they are manufactured, and what forms of verification they have undergone. This paper systematically reviews the current state of traceability for this category of ingredients across the following dimensions: ingredient source classification, strain acquisition pathways, principal production processes, supply chain documentation systems, and information transparency standards. It is intended to provide an objective reference framework for industry practitioners and consumers.

---

I. Classification and Overview of LAB Ingredient Sources

Lactic acid bacteria and probiotic ingredients exist commercially in three primary forms: viable freeze-dried powder, heat-treated inactivated cells (also referred to as "heat-processed lactic acid bacteria" or postbiotic precursors), and cell extracts. Each form corresponds to different ingredient sourcing pathways and documentation requirements.

Strain Repository Sources

The primary channels through which commercial LAB strains are originally obtained include: ① isolates derived from the human body (gastrointestinal tract, oral cavity) or from animals; ② strains selected from traditional fermented foods (dairy products, kimchi, natto, etc.); and ③ reference strains obtained by research institutions or companies from public microbial culture collections (such as ATCC, DSM, JCM, etc.).

Once a strain is identified, the original isolating institution or rights holder typically maintains a Master Cell Bank, from which a Working Cell Bank system is established. Downstream manufacturers then conduct large-scale fermentation starting from the working cell bank. This "dual-bank system" constitutes the core documentation node for strain source traceability.

Major Countries of Origin and Supply Landscape

The principal global suppliers of LAB ingredients include Denmark (home to large fermentation enterprises such as Chr. Hansen), France, the United States, domestic producers, and China. The proportion of imported ingredients in the market varies by product category: certain functional strains (such as specific *Lactiplantibacillus plantarum* and *Lacticaseibacillus rhamnosus* strains) are sourced primarily from Europe and the Americas, while domestic manufacturers have also developed proprietary patented strains, including domestically isolated strains used in specific fermented dairy products.

---

II. Fermentation Production Processes and Process Controls

2.1 Traceability of Culture Medium Ingredients

Industrial fermentation of lactic acid bacteria requires carbon sources (glucose, lactose, sucrose, etc.), nitrogen sources (peptone, yeast extract, etc.), and various trace minerals. These culture medium ingredients themselves are also subject to questions of origin labeling.

• Dairy-derived culture media: Where dairy-sourced nitrogen sources such as whey protein or casein hydrolysates are used, allergen labeling and ingredient origin must be reflected in batch records. Japan's Food Sanitation Act applies allergen labeling requirements to finished products, while documentation traceability at the ingredient level is covered by the GMP system.
• Non-dairy culture media: The use of plant-derived nitrogen sources (such as soy peptides) is more common in products targeting consumers with lactose intolerance or dairy protein allergies, and correspondingly requires a Non-GMO Certificate and a declaration of ingredient origin.

2.2 Fermentation and Downstream Processing

Upon completion of fermentation, the cell broth is concentrated by centrifugation or filtration, then proceeds to freeze-drying or spray-drying to yield dried bacterial powder. Cryoprotectants used in the freeze-drying process (trehalose, skim milk powder, maltodextrin, etc.) also constitute part of the final ingredient and must be incorporated into ingredient labeling and batch traceability documentation.

Key Traceability Nodes:

Fermentation batch number → working cell bank batch number → culture medium ingredient batch number → freeze-dried powder batch number → excipient batch number → finished product batch number

The completeness of this chain forms the foundation of the ingredient traceability documentation system and is a primary focus of GMP audits.

---

III. Quality Certification Systems Applicable to the Market

3.1 JHNFA GMP Certification

The GMP Certification (GMP) implemented by the Japan Health and Nutrition Food Association (JHNFA) is one of the most representative third-party certifications in Japan's health food manufacturing sector. This certification requires audited facilities to meet prescribed standards in areas including raw material incoming inspection, batch management, finished product release testing, and record retention; the audit scope encompasses ingredient origin and supplier qualification review.

Facilities that have obtained this certification are subject to periodic renewal audits, and certification information is publicly accessible on the JHNFA website, allowing consumers and purchasers to verify facility status using the certification number.

3.2 ISO 22000 and FSSC 22000

Ingredient suppliers engaged in export or working with international brands are typically also required to hold ISO 22000 (Food Safety Management Systems) or FSSC 22000 certification, the hazard analysis (HACCP) requirements of which encompass raw material supplier assessment and ingredient verification procedures.

3.3 Strain Safety Documentation

Probiotic strains intended for use in human food should, in principle, be supported by one or more of the following documents:

• QPS (Qualified Presumption of Safety): A strain safety presumption list established by the European Food Safety Authority (EFSA);
• GRAS (Generally Recognized as Safe): A safety recognition designation issued by the U.S. FDA;
• Food Safety Assessment Report: In Japan, applications for Foods with Function Claims submitted to the Consumer Affairs Agency require that ingredient safety be supported by a systematic review (SR) document.

---

IV. Documentation Systems for Supply Chain Traceability

4.1 Supplier Qualification

A rigorous procurement process requires written qualification review of LAB ingredient suppliers, typically covering:

• Verification of business license and manufacturing permit
• Confirmation of GMP certificate validity
• Review of the Certificate of Analysis (CoA), covering viable cell count, moisture content, heavy metals, and microbiological contamination indicators
• Declaration of origin and Non-GMO certificate (where applicable)
• Allergen management declaration

4.2 Batch Records and CoA Interpretation

The CoA for each batch of LAB freeze-dried powder should indicate the following verifiable information:

• Strain scientific name (including species and strain designation, e.g., *Lactiplantibacillus plantarum* LP-115)
• Viable cell count (CFU/g), with the analytical method specified (e.g., ISO 19344)
• Moisture content
• Contaminant organism limits
• Heavy metal (lead, arsenic, mercury, cadmium) test results
• Date of manufacture and expiry date
• Strain source batch number (linked to seed bank)

When a CoA identifies the strain only by genus-level designation (e.g., "lactic acid bacteria") without further specification, a gap exists in supply chain transparency, and downstream manufacturers should require the supplier to provide supplementary documentation specifying the precise strain designation.

4.3 Labeling Levels for Origin Information

In the market, there is currently no unified mandatory requirement for labeling the origin of ingredients in health foods (*JAS Act* and *Food Sanitation Act* provisions apply primarily to specific items in processed foods). However, application materials submitted under the Foods with Function Claims system must include source information for primary ingredients. Some companies voluntarily disclose ingredient origins and supplier information on product packaging or corporate websites, a practice regarded as a positive demonstration of information transparency.

---

V. Industry Trends in Ingredient Transparency

5.1 Strain Patents and Traceability Verifiability

Strains with commercial value are typically protected by patents, and patent publications record the strain's isolation source, taxonomic identification methodology, and depository accession number (e.g., NITE-NBRC or DSMZ accession numbers). Consumers or researchers can search relevant strain information through J-PlatPat (Japan's patent database) or Espacenet, constituting an important pathway through which strain origins can be publicly verified.

5.2 Blockchain and Digital Traceability

Some food companies have piloted the recording of ingredient batch information on blockchain, enabling consumers to scan a code and view the production facility, batch number, and key test results for the ingredient in question. Given the short batch cycles and active quality indicators involved in LAB ingredients, digital batch traceability offers considerable practical value; however, adoption across Japan's health food industry currently remains at an early stage.

5.3 Third-Party Testing and Public Disclosure

Another dimension of industry transparency is the public disclosure of independent third-party test reports. Some manufacturers commission institutions such as the Japan Food Research Laboratories (JFRL) and the Japan Food Hygiene Association to conduct independent viable cell count verification and contaminant testing, and publish report summaries on their corporate websites. This practice helps reduce information asymmetry for consumers and represents a meaningful distinction from reliance solely on supplier-issued CoAs.

---

VI. Practical Guidance for Consumers

When evaluating the wide variety of LAB- and probiotic-containing health foods on the market, consumers interested in ingredient traceability and origin information will find the following points practically actionable:

• 1. Verify the specific strain name

If a product label states only "contains lactic acid bacteria" without listing the specific strain scientific name (genus + species + strain designation), the traceability of the ingredient source is limited. Prioritize products that specify the strain name; the strain name can then be used to search existing research literature in academic databases such as PubMed.

• 2. Confirm the manufacturing facility's GMP certification status

JHNFA GMP Certification information in Japan can be searched on the JHNFA website; entering the certification number allows verification of certification validity and scope. Selecting products manufactured at facilities that have obtained third-party GMP certification is a fundamental reference indicator of ingredient management standards.

• 3. Consult the Foods with Function Claims notification information

If a product is sold as a Food with Function Claims, its notification materials—including the SR report and safety assessment documents—are publicly available in full on the Consumer Affairs Agency database, and consumers can directly access information on ingredient sources and supporting literature.

• 4. Review ingredient information disclosures on corporate websites

Some companies maintain dedicated pages such as "About Our Ingredients" or "Quality Management" on their websites, publicly disclosing primary ingredient origins and supplier qualification mechanisms. This is a voluntary indicator of corporate information transparency.

• 5. Pay attention to allergen labeling for excipients and cryoprotectants

Freeze-dried LAB powders frequently contain dairy-derived excipients such as lactose and skim milk powder. Consumers with dairy protein allergies should carefully review allergen labeling in the ingredient list and, where necessary, confirm excipient sources directly with the manufacturer.

• 6. Take a rational approach to viable cell count labeling and shelf life

Viable cell count (CFU) is the core quality indicator for LAB ingredients. It is important to distinguish between "viable count at time of manufacture" and "guaranteed viable count within the shelf life period"—the former is typically higher than the actual count at the time of consumption. Compliant product labeling should specify the conditions under which the guaranteed value was determined, such as storage temperature and the time point of measurement.

---

Conclusion

The supply chain transparency of lactic acid bacteria and probiotic ingredients is, at its core, a question of information symmetry. From the strain seed bank, fermentation batch records, and freeze-drying processing through to final product release, every stage contains information nodes that can be documented, audited, and independently verified by third parties. Japan's market has established an information framework anchored by JHNFA GMP certification, the Foods with Function Claims notification system, and public disclosure of third-party test results, providing a foundational institutional guarantee for ingredient traceability.

For consumers, improving ingredient traceability capabilities depends on: being able to read and understand strain names and key indicators in CoAs; knowing where to search for manufacturing facility certification status; and distinguishing which information in product labeling is verifiable and which constitutes vague assertion. For industry practitioners, proactively disclosing ingredient origins, strengthening batch documentation systems, and cooperating with third-party certification audits are the core pathways to enhancing supply chain credibility.

Supply chain transparency is not a destination but a process requiring continuous updating and verification. As digital traceability technology advances and international ingredient regulatory standards converge, the disclosure of LAB ingredient information in Japan's health food industry can be expected to evolve toward greater granularity and greater real-time accessibility in the future.